Horizon Bancorp’s Elevance Health ELV Stock Holding History

Horizon Bancorp’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$226K	Sell	771 -334	-30%	-$110K	0.11%	70
2025 Q4	$387K	Sell	1,105 -236	-18%	-$79.8K	0.19%	41
2025 Q3	$433K	Buy	1,341 +15	+1%	+$4.67K	0.21%	41
2025 Q2	$516K	Sell	1,326 -52	-4%	-$20.9K	0.26%	42
2025 Q1	$599K	Sell	1,378 -2	-0.1%	-$803	0.34%	29
2024 Q4	$509K	Sell	1,380 -6	-0.4%	-$2.51K	0.24%	31
2024 Q3	$721K	Buy	1,386 +632	+84%	+$338K	0.33%	24
2024 Q2	$409K	Hold	754	–	–	0.19%	34
2024 Q1	$391K	Sell	754 -32	-4%	-$15.9K	0.19%	37
2023 Q4	$371K	Hold	786	–	–	0.18%	33
2023 Q3	$342K	Hold	786	–	–	0.22%	26
2023 Q2	$349K	Hold	786	–	–	0.22%	19
2023 Q1	$361K	Sell	786 -68	-8%	-$32.4K	0.23%	11
2022 Q4	$438K	Buy	+854	New	+$434K	0.25%	25
2020 Q3	$254K	Hold	946	–	–	0.36%	82
2020 Q2	$249K	Hold	946	–	–	0.27%	74
2020 Q1	$215K	Hold	946	–	–	0.33%	81
2019 Q4	$286K	Buy	+946	New	+$260K	0.27%	99

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Horizon Bancorp's ELV Position: Q1 2026 in Review

Horizon Bancorp reduced its Elevance Health (ELV) stake by 30% in Q1 2026, selling an estimated $110K and leaving 771 shares worth $226K. The position accounts for 0.11% of the portfolio, ranked #70.

Horizon Bancorp first reported a position in ELV in Q4 2019 and has held it in 18 quarters since. The position peaked at $721K in Q3 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Horizon Bancorp held 771 shares of Elevance Health worth $226K as of Q1 2026.
Horizon Bancorp sold 334 Elevance Health shares in Q1 2026, an estimated $110K.
Elevance Health made up 0.11% of Horizon Bancorp's portfolio in Q1 2026, its #70 holding.
Horizon Bancorp first reported a position in Elevance Health in Q4 2019 and has held it in 18 quarters since.
Horizon Bancorp's Elevance Health position peaked at $721K in Q3 2024.
1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Horizon Bancorp's 13F filing for Q1 2026, filed 22 Apr 2026.